SynthesisMedicine2020

Oncological outcomes of addition of anti-PD1/PD-L1 to chemotherapy in the therapy of patients with advanced gastric or gastro-oesophageal junction cancer: A meta-analysis.

Zheng Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.